Ohki Healthcare Holdings Co.,Ltd. (TYO:3417)
1,328.00
+17.00 (1.30%)
Feb 13, 2026, 3:30 PM JST
Ohki Healthcare Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 359,405 | 349,452 | 334,661 | 304,445 | 278,162 | 286,173 | |
Revenue Growth (YoY) | 3.98% | 4.42% | 9.93% | 9.45% | -2.80% | 3.21% |
Cost of Revenue | 340,332 | 330,942 | 317,460 | 288,563 | 264,437 | 256,584 |
Gross Profit | 19,073 | 18,510 | 17,201 | 15,882 | 13,725 | 29,589 |
Selling, General & Admin | 16,167 | 15,408 | 14,811 | 13,496 | 12,745 | 26,185 |
Research & Development | 19 | 19 | 24 | 24 | 42 | 67 |
Operating Expenses | 16,500 | 15,741 | 15,157 | 13,822 | 13,093 | 26,579 |
Operating Income | 2,573 | 2,769 | 2,044 | 2,060 | 632 | 3,010 |
Interest Expense | -129 | -71 | -35 | -33 | -36 | -40 |
Interest & Investment Income | 259 | 222 | 203 | 183 | 185 | 309 |
Other Non Operating Income (Expenses) | 1,121 | 1,070 | 1,047 | 943 | 803 | 827 |
EBT Excluding Unusual Items | 3,824 | 3,990 | 3,259 | 3,153 | 1,584 | 4,106 |
Gain (Loss) on Sale of Investments | 12 | 13 | 3 | 24 | - | 100 |
Gain (Loss) on Sale of Assets | 2 | - | -63 | - | - | - |
Asset Writedown | -5 | -5 | - | - | - | -1 |
Other Unusual Items | -243 | -167 | 206 | 4 | -52 | -82 |
Pretax Income | 3,590 | 3,831 | 3,405 | 3,181 | 1,532 | 4,123 |
Income Tax Expense | 1,157 | 1,188 | 1,278 | 998 | 605 | 1,231 |
Earnings From Continuing Operations | 2,433 | 2,643 | 2,127 | 2,183 | 927 | 2,892 |
Minority Interest in Earnings | 1 | -4 | 83 | -1 | 45 | -96 |
Net Income | 2,434 | 2,639 | 2,210 | 2,182 | 972 | 2,796 |
Net Income to Common | 2,434 | 2,639 | 2,210 | 2,182 | 972 | 2,796 |
Net Income Growth | 4.15% | 19.41% | 1.28% | 124.49% | -65.24% | 18.17% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | -0.16% | -0.97% | -0.12% | - | -0.00% | -0.52% |
EPS (Basic) | 178.43 | 193.46 | 160.43 | 158.21 | 70.48 | 202.73 |
EPS (Diluted) | 178.43 | 193.46 | 160.43 | 158.21 | 70.48 | 202.73 |
EPS Growth | 4.32% | 20.59% | 1.40% | 124.49% | -65.24% | 18.79% |
Free Cash Flow | - | -12,026 | 7,271 | -138 | 1,218 | -4,401 |
Free Cash Flow Per Share | - | -881.58 | 527.82 | -10.01 | 88.31 | -319.11 |
Dividend Per Share | 26.000 | 26.000 | 24.000 | 22.000 | 21.000 | 20.000 |
Dividend Growth | 8.33% | 8.33% | 9.09% | 4.76% | 5.00% | 5.26% |
Gross Margin | 5.31% | 5.30% | 5.14% | 5.22% | 4.93% | 10.34% |
Operating Margin | 0.72% | 0.79% | 0.61% | 0.68% | 0.23% | 1.05% |
Profit Margin | 0.68% | 0.76% | 0.66% | 0.72% | 0.35% | 0.98% |
Free Cash Flow Margin | - | -3.44% | 2.17% | -0.04% | 0.44% | -1.54% |
EBITDA | 2,968 | 3,156 | 2,421 | 2,435 | 1,013 | 3,406 |
EBITDA Margin | 0.83% | 0.90% | 0.72% | 0.80% | 0.36% | 1.19% |
D&A For EBITDA | 394.5 | 387 | 377 | 375 | 381 | 396 |
EBIT | 2,573 | 2,769 | 2,044 | 2,060 | 632 | 3,010 |
EBIT Margin | 0.72% | 0.79% | 0.61% | 0.68% | 0.23% | 1.05% |
Effective Tax Rate | 32.23% | 31.01% | 37.53% | 31.37% | 39.49% | 29.86% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.